VASCADE VCS is a fully integrated, extravascular, bioabsorbable femoral access closure system that is easy to use, leaves no permanent components behind, and has demonstrated safety and efficacy in a wide range of patients. The system combines Cardiva’s proven proprietary collapsible disc technology and a thrombogenic resorbable collagen patch in an integrated design. For patients and healthcare providers, VASCADE enables rapid hemostasis while minimizing complications.
Features and Benefits
VASCADE VCS Is Safe, Effective and Easy to Use
VASCADE offers superior safety and efficacy as compared to manual compression. Additionally, VASCADE is easy to use and provides these benefits:
- Simple-to-use technique with no sheath exchange to easily deploy collagen
- Unique design maintains collagen patch position during sleeve retraction and device removal
- Patented disc technology efficiently locates arteriotomy or venotomy for precise placement and release of pre-loaded patch
- Proven technology that has been used in more than 500,000 procedures
- Fully-integrated femoral access closure system
Dual Method of Action Accelerates Hemostasis
Benefits of Mechanical Hemostasis
VASCADE provides tamponade as a result of rapid expansion of collagen in presence of fluid.3,4 Approximately 13x expansion in collagen patch ensures tissue tract is sufficiently filled and provides mechanical hemostasis.
Benefits of Physiological Hemostasis
VASCADE accelerates coagulation by leveraging natural thrombogenic properties of collagen to enhance coagulation. In vitro testing demonstrates VASCADE collagen decreases clotting time in both heparinized and non-heparinized blood as compared against control (porcine blood).